Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Toxic metabolic disorder

While ammonia, derived mainly from the a-amino nitrogen of amino acids, is highly toxic, tissues convert ammonia to the amide nitrogen of nontoxic glutamine. Subsequent deamination of glutamine in the liver releases ammonia, which is then converted to nontoxic urea. If liver function is compromised, as in cirrhosis or hepatitis, elevated blood ammonia levels generate clinical signs and symptoms. Rare metabolic disorders involve each of the five urea cycle enzymes. [Pg.242]

The antiseizure drugs described in this chapter are also used in patients with febrile seizures or with seizures occurring as part of an acute illness such as meningitis. The term "epilepsy" is not usually applied to such patients unless chronic seizures develop later. Seizures are occasionally caused by an acute underlying toxic or metabolic disorder, in which case appropriate therapy should be directed toward the specific abnormality, eg, hypocalcemia. In most cases of epilepsy, however, the choice of medication depends on the empiric seizure classification. [Pg.508]

Sugar is one of the purest foods made, from natural sources, and has never been known to contain any toxic or harmful components. Intensive investigations by the U.S. Food and Drug Administration resulted in a book in 1986 on the health and safety factors of sugar (cane and beet) in the diet (18). The conclusion was that sugar has no deleterious effect on health in regard to heart disease, diabetes, or other metabolic disorder. [Pg.21]

Most metabolic disorders are inherited, meaning that they are passed by parents to their offspring in defective genes. Also, they have no cure. They are usually treated with medications and a special diet to provide the missing substances or remove the toxic ones that build up. [Pg.63]

IUGR) with elevated risk levels of these diseases (Lau Rogers, 2005). The basis of the association is believed to be that alterations in nutrient availability (or other environmental stressors) lead to short-term adaptive measures in the fetus (involving altered homeostatic set-points) that later result in metabolic disorders when the stressor is relieved. The metabolic alterations, in turn, then gradually contribute to increased risk with ageing. It is important to note that functional developmental toxicity may be evident only after long latency periods and may be difficult to ascertain due to the functional reserve capacity of many organ systems. [Pg.68]

Elemental analysis of body tissues and fluids by atomic absorption spectrometry with electrothermal atomisation has advanced significantly the understanding of the role of trace elements in clinical biochemistry. All of those aspects of metabolic processes that are affected by changes in the concentrations of accessible trace elements have been studied. These include deficiencies of essential trace elements as a result of inherited or acquired metabolic disorders, or from nutritional inadequacy and excesses of trace elements producing toxicity states as a result of inherited metabolic disorders involving essential trace elements or from the inappropriate exposure to, or ingestion of, non-essential trace elements. [Pg.341]

Encephalopathy can occur in a number of extrahepatic diseases, such as toxic, metabolic or circulatory disorders, intracranial space-occupying lesions, hypothyroidism (35) and neurological/psychiatric diseases, (s. tab. 15.2) Identification of neuropsychiatric symptoms always calls for careful differential diagnosis. [Pg.275]

Uremic toxins are chemicals and waste products normally excreted by the kidneys and are responsible for many of the signs of kidney disease. Since 1840, more than 2000 toxic substances were reported in uremic blood. Obviously, the determination of such compounds is crucial for diagnosis and monitoring of renal disease and metabolic disorders. The concentrations of several uremic toxins in blood serum and urine are among the most important parameters in biochemistry and clinical chemistry. [Pg.1688]

Bisacylphosphonates (50) and bishydroxyiminophosphonates (51) were found to be the first examples of non-geminal bisphosphonates biologically active in calcium metabolism disorders such as pathological calcification and bone resorption These compounds showed less toxic side-effects and improved bioavailability than bisphosphonates approved for clinical use. ... [Pg.723]

Aspirin as a single drug is very effective as a painkiller but causes stomach irritation or ulceration. Therefore, to minimize the side effects a combination with antacids is generally prescribed. An appropriate example of multiherbal formulations is seen in most hepatopro-tective preparations. Among the few prescribed herbal preparations in the market, Liv-52, a mixture of more than 20 medicinal plants, is effective in the treatment of common liver disorders. Here a single drug may not be that effective, as liver toxicity may be a manifestation of several metabolic disorders caused by toxins and pollutants. [Pg.37]

PPAR agonists have shown great promise as new therapeutics for the treatment of diabetes, dyshpidemia, and related metabolic disorders. Safety has been an issue and a concern, especially due to lack of proper understanding of the mechanism of toxicity and side effects. The compounds are being discontinued from clinical development due to nonspecific tumors seen in a two-year carcinogenicity study in rodents. Pioglitazone, which has been on Ihe market since 2000, had also shown tumors in rodents. However, as the understanding of concern becomes clear, insulin sensitizers would become important therapeutic tools for the treatment of diabetes. [Pg.116]

The preparations are featured with combining probiotics and prebiotics (mannans and glucans on cell walls of yeast Saccharomyces cerevisiae), and phytobiotics of the medicinal plants - Echinacea purpurea and holy thistle. Echinacea has immunomodulatory properties. Echinacea preparations exhibit antibacterial, antiviral and antifungal properties. When intaking the Echinacea preparations at metabolic disorders, at the impact of different chemical compounds of toxic nature, contained in the feed (heavy metals, pesticides, insecticides, fungicides), a stimulation of the immune system has been observed. [Pg.316]


See other pages where Toxic metabolic disorder is mentioned: [Pg.286]    [Pg.286]    [Pg.171]    [Pg.286]    [Pg.286]    [Pg.171]    [Pg.310]    [Pg.470]    [Pg.121]    [Pg.8]    [Pg.117]    [Pg.77]    [Pg.293]    [Pg.371]    [Pg.293]    [Pg.526]    [Pg.544]    [Pg.341]    [Pg.780]    [Pg.93]    [Pg.61]    [Pg.110]    [Pg.509]    [Pg.310]    [Pg.116]    [Pg.247]    [Pg.457]    [Pg.52]    [Pg.61]    [Pg.4314]    [Pg.99]    [Pg.131]    [Pg.410]    [Pg.3815]    [Pg.121]    [Pg.295]    [Pg.120]    [Pg.539]   
See also in sourсe #XX -- [ Pg.286 ]




SEARCH



Metabolic disorder

Metabolism disorders

Toxic disorders

Toxicant metabolism

© 2024 chempedia.info